Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Blocking TYK2 might be a new way to treat hair loss from alopecia areata.

Alopecia areata involves immune response and gene changes affecting hair loss.

The TRPV3 channel structure changes linked to severe itch and hyperkeratosis were identified using cryo-EM.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Reprogramming wound-repair cells can improve healing of chronic wounds.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

CD8A and FOXD2-AS1 may be key for diagnosing and treating alopecia areata.

Antisense oligonucleotides can reduce androgen receptor levels in skin cells, suggesting potential for treating skin disorders.

Ritlecitinib can reduce inflammation and help hair regrow in Alopecia Areata.

Hair protects the scalp from skin cancer by aiding immune defense.

Baricitinib successfully treated severe hair loss.

Higher nitric oxide synthase levels in the scalp may influence hair loss in androgenetic alopecia.

Monkey hair cortisol levels are not affected by how fast their hair grows.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

Improved CRBN ligands make protein degraders more effective and drug-like.

Childhood and adult height, and early immune-related hospitalizations increase testicular cancer risk, while baldness, larger families, and sports reduce it.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Alopecia areata treatments include immune inhibitors, topical sensitizers, irritants, and minoxidil, with future focus on immunosuppressive approaches.

Direct-to-consumer teledermatology is not effectively reaching underserved populations due to language, technology, and insurance barriers.

Asiasari radix extract may be a potential treatment for melanoma because it selectively triggers cell death in melanoma cells by affecting p53 regulation.

Certain factors like being female, having high cholesterol, using Medicaid, and previous non-biologic treatments increase the risk of multiple biologic failures in psoriasis patients.

NB-002 is a promising new topical treatment for fungal nail infections, showing better results than a non-medicated option.

Both cell and non-cell parts are important for rat whisker follicle regrowth.

PCR genotyping in cre-loxP mice can be inaccurate due to unintended gene deletions in non-target tissues.

Plucked hair follicles can help diagnose scalp lupus.